Media Summary: Marlise Luskin, MD, MSCE, is a physician in In this video, Dr. Robert Soiffer, Chief of the Division of Hematologic Malignancies at A panel of patients joined Tracy Bell, RN, to discuss the process of investigating possible

Improving Access To Blood Cancer Clinical Trials Dana Farber Cancer Institute - Detailed Analysis & Overview

Marlise Luskin, MD, MSCE, is a physician in In this video, Dr. Robert Soiffer, Chief of the Division of Hematologic Malignancies at A panel of patients joined Tracy Bell, RN, to discuss the process of investigating possible Irene Ghobrial, MD, and Matthew Davids, MD, discuss new immunotherapies and how they are being used to treat A patient shares her journey getting diagnosed with chronic lymphocytic leukemia in her 30's. Slides for this presentation are available on

Photo Gallery

Improving access to blood cancer clinical trials | Dana-Farber Cancer Institute
What is it like to participate in a clinical trial? | Dana-Farber Cancer Institute
Dr. Luskin on leukemia treatment | Dana-Farber Cancer Institute
Blood Cancer Research: Targeted therapy in multiple myeloma
Dr. Soiffer on treating patients with blood cancers | Dana-Farber Cancer Institute
Center for Prevention of Progression of Blood Cancers | Dana-Farber Cancer Institute
Behind the Breakthroughs: New Hope, New Options for Lymphoid and Myeloid Cancers
The Latest in Clinical Trials for Brain Tumor Patients | Dana-Farber Cancer Institute
Navigating Clinical Trials
What is the Latest in Using Immunotherapy to Treat Blood Cancers? | Dana-Farber Cancer Institute
Blood Cancer Research: Clinical trial helps younger patient
Clinical Trials for Brain Tumor Patients | Dana-Farber Cancer Institute
Sponsored
Sponsored
View Detailed Profile
Improving access to blood cancer clinical trials | Dana-Farber Cancer Institute

Improving access to blood cancer clinical trials | Dana-Farber Cancer Institute

The

What is it like to participate in a clinical trial? | Dana-Farber Cancer Institute

What is it like to participate in a clinical trial? | Dana-Farber Cancer Institute

Julia Rotow, MD,

Sponsored
Dr. Luskin on leukemia treatment | Dana-Farber Cancer Institute

Dr. Luskin on leukemia treatment | Dana-Farber Cancer Institute

Marlise Luskin, MD, MSCE, is a physician in

Blood Cancer Research: Targeted therapy in multiple myeloma

Blood Cancer Research: Targeted therapy in multiple myeloma

Dana

Dr. Soiffer on treating patients with blood cancers | Dana-Farber Cancer Institute

Dr. Soiffer on treating patients with blood cancers | Dana-Farber Cancer Institute

In this video, Dr. Robert Soiffer, Chief of the Division of Hematologic Malignancies at

Sponsored
Center for Prevention of Progression of Blood Cancers | Dana-Farber Cancer Institute

Center for Prevention of Progression of Blood Cancers | Dana-Farber Cancer Institute

The

Behind the Breakthroughs: New Hope, New Options for Lymphoid and Myeloid Cancers

Behind the Breakthroughs: New Hope, New Options for Lymphoid and Myeloid Cancers

Learn about

The Latest in Clinical Trials for Brain Tumor Patients | Dana-Farber Cancer Institute

The Latest in Clinical Trials for Brain Tumor Patients | Dana-Farber Cancer Institute

Patrick Wen, MD, director of

Navigating Clinical Trials

Navigating Clinical Trials

A panel of patients joined Tracy Bell, RN, to discuss the process of investigating possible

What is the Latest in Using Immunotherapy to Treat Blood Cancers? | Dana-Farber Cancer Institute

What is the Latest in Using Immunotherapy to Treat Blood Cancers? | Dana-Farber Cancer Institute

Irene Ghobrial, MD, and Matthew Davids, MD, discuss new immunotherapies and how they are being used to treat

Blood Cancer Research: Clinical trial helps younger patient

Blood Cancer Research: Clinical trial helps younger patient

A patient shares her journey getting diagnosed with chronic lymphocytic leukemia in her 30's.

Clinical Trials for Brain Tumor Patients | Dana-Farber Cancer Institute

Clinical Trials for Brain Tumor Patients | Dana-Farber Cancer Institute

Slides for this presentation are available on

Blood Cancer Research: Disparities in trials

Blood Cancer Research: Disparities in trials

Dana

How Can Precision Medicine Improve Cancer Diagnosis and Treatment? | Dana-Farber Cancer Institute

How Can Precision Medicine Improve Cancer Diagnosis and Treatment? | Dana-Farber Cancer Institute

How can patients benefit from the latest

Experimental drug improves survival in certain AML patients | Dana-Farber Cancer Institute

Experimental drug improves survival in certain AML patients | Dana-Farber Cancer Institute

Dana

Improving outcomes for myeloid cancers

Improving outcomes for myeloid cancers

Improving

Clinical Trials for Esophageal and Gastric Cancer - Digesting the Science: A Series

Clinical Trials for Esophageal and Gastric Cancer - Digesting the Science: A Series

The

Overview of Therapy of Lymphoma | Dana-Farber Cancer Institute

Overview of Therapy of Lymphoma | Dana-Farber Cancer Institute

For more information on

Why do Basic Research in a Cancer Institute? | Dana-Farber Cancer Institute

Why do Basic Research in a Cancer Institute? | Dana-Farber Cancer Institute

For more information about